Hong Jiang1, Rong Wang, Yan Liu, Yun Zhang, Zhe-Yu Chen. 1. Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China.
Abstract
BACKGROUND: Brain-derived neurotrophic factor (BDNF) is involved in the pathophysiology of coronary artery disease (CAD). The human BDNF Val66Met polymorphism has been shown to be associated with altered susceptibility to neuropsychiatric disorders. However it is unknown whether this polymorphism plays a role in cardiovascular disease. METHODS: Genotyping of BDNF Val66Met polymorphism was carried out in 513 controls, 628 unstable angina pectoris (UAP) and 276 stable angina pectoris (SAP) patients. The plasma concentrations of BDNF and high-sensitivity C-reactive protein (hsCRP) were measured by ELISA. The general clinical data in patients and controls were obtained. RESULTS: There was a significant association between genotype and allele frequency of the BDNF Val66Met polymorphism and UAP (all P<0.05). Multivariate logistic regression analysis revealed that the BDNF(Met/Met) genotype had a protective effect on the occurrence of UAP after controlling for known risk factors of CAD (OR 0.53, P=0.005). Subjects with BDNF(Met/Met) genotype also had decreased plasma hsCRP levels compared with the Val carriers (P<0.01). CONCLUSION: The BDNF(Met/Met) genotype has a protective effect on the occurrence of UAP, which might in part be due to the decreased plasma hsCRP level in BDNF(Met/Met) carriers. To our knowledge, this is the first study that demonstrates the link between BDNF Val66Met polymorphism and CAD.
BACKGROUND:Brain-derived neurotrophic factor (BDNF) is involved in the pathophysiology of coronary artery disease (CAD). The humanBDNF Val66Met polymorphism has been shown to be associated with altered susceptibility to neuropsychiatric disorders. However it is unknown whether this polymorphism plays a role in cardiovascular disease. METHODS: Genotyping of BDNF Val66Met polymorphism was carried out in 513 controls, 628 unstable angina pectoris (UAP) and 276 stable angina pectoris (SAP) patients. The plasma concentrations of BDNF and high-sensitivity C-reactive protein (hsCRP) were measured by ELISA. The general clinical data in patients and controls were obtained. RESULTS: There was a significant association between genotype and allele frequency of the BDNF Val66Met polymorphism and UAP (all P<0.05). Multivariate logistic regression analysis revealed that the BDNF(Met/Met) genotype had a protective effect on the occurrence of UAP after controlling for known risk factors of CAD (OR 0.53, P=0.005). Subjects with BDNF(Met/Met) genotype also had decreased plasma hsCRP levels compared with the Val carriers (P<0.01). CONCLUSION: The BDNF(Met/Met) genotype has a protective effect on the occurrence of UAP, which might in part be due to the decreased plasma hsCRP level in BDNF(Met/Met) carriers. To our knowledge, this is the first study that demonstrates the link between BDNF Val66Met polymorphism and CAD.
Authors: Antonio Terracciano; Maria Grazia Piras; Monia Lobina; Antonella Mulas; Osorio Meirelles; Angelina R Sutin; Wayne Chan; Serena Sanna; Manuela Uda; Laura Crisponi; David Schlessinger Journal: World J Biol Psychiatry Date: 2011-11-02 Impact factor: 4.132
Authors: A Terracciano; B Martin; D Ansari; T Tanaka; L Ferrucci; S Maudsley; M P Mattson; P T Costa Journal: Genes Brain Behav Date: 2010-03-22 Impact factor: 3.449
Authors: Rong Jiang; Michael A Babyak; Beverly H Brummett; Elizabeth R Hauser; Svati H Shah; Richard C Becker; Ilene C Siegler; Abanish Singh; Carol Haynes; Megan Chryst-Ladd; Damian M Craig; Redford B Williams Journal: Am Heart J Date: 2017-05-18 Impact factor: 4.749
Authors: Patrizia Amadio; Gualtiero I Colombo; Eva Tarantino; Sara Gianellini; Alessandro Ieraci; Maura Brioschi; Cristina Banfi; José P Werba; Alessandro Parolari; Francis S Lee; Elena Tremoli; Silvia S Barbieri Journal: Eur Heart J Date: 2017-05-07 Impact factor: 29.983